Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate

J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):415-6. doi: 10.1136/jnnp.70.3.415.
No abstract available

Publication types

  • Letter

MeSH terms

  • Glatiramer Acetate
  • Humans
  • Lymphatic Diseases / etiology*
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy*
  • Peptides / adverse effects
  • Peptides / therapeutic use*

Substances

  • Peptides
  • Glatiramer Acetate